Response to Letter to the Editor by Johnston and Fotiadis regarding “Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review.”

First, we appreciate the authors interest in our research. We completely agree that radiofrequency ablation (RFA) has a higher level of evidence than stereotactic body radiotherapy (SBRT). Because of the difference in evidence level, RFA or surgery is considered the standard treatment for liver malignancies, whereas radiotherapy is indicated for patients who are not candidates to these treatments [1 –3]. Most studies included in our meta-analysis [4] were conducted by radiation oncologists who treated patients with SBRT and compared with statistically and/or propensity matched cohorts.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Source Type: research